Home › Funds › HighVista Strategies LLC › GMAB
HighVista Strategies LLC position in GMAB
GENMAB A/S · Health Care
HighVista Strategies LLC reported holding 226,098 shares of GMAB (GENMAB A/S) in its Q3 2026 13F filing — a position valued at US$8.1M, representing 2.12% of its reported portfolio and ranking #5 among its reported holdings. HighVista Strategies LLC first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How HighVista Strategies LLC's GMAB position evolved
HighVista Strategies LLC first disclosed a stake in GMAB in Q3 2026 at 226,098 shares (US$8.1M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 226.10K | $8.07M | New |
About GMAB and 13F data
GMAB (GENMAB A/S) is a Health Care company. 35 other funds we track also report a position in GMAB — the largest reported positions include Paradigm Biocapital Advisors LP (US$360.8M), Orbis Allan Gray Ltd (US$312.3M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$188.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMAB
- Paradigm Biocapital Advisors LP 13.13M sh · $360.77M · Q2 2026
- Orbis Allan Gray Ltd 11.37M sh · $312.28M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 6.87M sh · $188.58M · Q2 2026
- Sofinnova Investments, Inc. 4.05M sh · $111.12M · Q2 2026
- HARDING LOEVNER LP 3.09M sh · $86.90M · Q2 2026
- Deep Track Capital, LP 3.00M sh · $82.41M · Q2 2026
- Dixon Mitchell Investment Counsel Inc. 407.00K sh · $14.52M · Q3 2026
More on HighVista Strategies LLC
FAQ
How long has HighVista Strategies LLC held GMAB?
HighVista Strategies LLC has disclosed GMAB holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is HighVista Strategies LLC's current position in GMAB?
As of Q3 2026, HighVista Strategies LLC holds 226.10K shares of GMAB (GENMAB A/S), valued at $8.07M, representing 2.12% of its reported portfolio and ranking #5.
Has HighVista Strategies LLC been buying or selling GMAB?
In the latest 13F filing (Q3 2026), HighVista Strategies LLC newly opened its position in GMAB.
Which other funds hold GMAB?
Other major institutional holders of GMAB include Paradigm Biocapital Advisors LP, Orbis Allan Gray Ltd, DEERFIELD MANAGEMENT COMPANY, L.P., among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.